Drug Safety & Pharmacovigilance Software Market Trends, and Forecast 2020-2030: Present Scenario, User Demand, Growth Analysis and Regional Overview
The global drug safety and pharmacovigilance software market accounted for over US$ 148.4 Million in 2019. It is anticipated to grow at a CAGR of 6.3% from 2020 to 2030. The growth of the drug safety and pharmacovigilance software market can be attributed to several factors such as the increasing adoption of pharmacovigilance software by outsourcing companies and the rising incidents of Adverse Drug Reactions (ARDs). Contract research organizations are actively participating in the research & development activities following the rising prevalence of chronic diseases across the globe, which is likely to boost the overall market growth. Additionally, rising patient safety issues and surging adverse effects resulting from certain drug consumption may boost the global drug safety and pharmacovigilance market. This may also have a direct correlation with the availability of clinical trial services and decreased medical spending, and hence the potential growth demand for the future. Howe...